Literature DB >> 26440668

Inositol Hexakisphosphate Kinase 2 Promotes Cell Death in Cells with Cytoplasmic TDP-43 Aggregation.

Eiichiro Nagata1,2, Takashi Nonaka3, Yusuke Moriya4, Natsuko Fujii4, Yoshinori Okada5, Hideo Tsukamoto5, Johbu Itoh5, Chisa Okada5, Tadayuki Satoh5, Tetsuaki Arai6, Masato Hasegawa3, Shunya Takizawa4.   

Abstract

TAR DNA-binding protein 43 (TDP-43) has been identified as a major component of ubiquitin-positive inclusions in the brains and spinal cords of patients with frontotemporal lobar degeneration with ubiquitinated inclusions (FTLD-U) or amyotrophic lateral sclerosis (ALS). The phosphorylated C-terminal fragment of TDP-43 forms aggregates in the neuronal cytoplasm, possibly resulting in neuronal cell death in patients with FTLD-U or ALS. The inositol pyrophosphate known as diphosphoinositol pentakisphosphate (InsP7) contains highly energetic pyrophosphate bonds. We previously reported that inositol hexakisphosphate kinase type 2 (InsP6K2), which converts inositol hexakisphosphate (InsP6) to InsP7, mediates cell death in mammalian cells. Moreover, InsP6K2 is translocated from the nucleus to the cytosol during apoptosis. In this study, we verified that phosphorylated TDP-43 co-localized and co-bound with InsP6K2 in the cytoplasm of anterior horn cells of the spinal cord. Furthermore, we verified that cell death was augmented in the presence of cytoplasmic TDP-43 aggregations and activated InsP6K2. However, cells with only cytoplasmic TDP-43 aggregation survived because Akt activity increased. In the presence of both TDP-43 aggregation and activated InsP6K2 in the cytoplasm of cells, the expression levels of HSP90 and casein kinase 2 decreased, as the activity of Akt decreased. These conditions may promote cell death. Thus, InsP6K2 could cause neuronal cell death in patients with FTLD-U or ALS. Moreover, InsP6K2 plays an important role in a novel cell death pathway present in FTLD-U and ALS.

Entities:  

Keywords:  Akt; Amyotrophic lateral sclerosis (ALS); Casein kinase 2; Cell death; Frontotemporal lobar degeneration with ubiquitinated inclusions (FTLD-U); HSP90; Inositol hexakisphosphate kinase 2 (InsP6K2); TDP-43

Mesh:

Substances:

Year:  2015        PMID: 26440668     DOI: 10.1007/s12035-015-9470-1

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  44 in total

1.  Identification and characterization of a novel inositol hexakisphosphate kinase.

Authors:  A Saiardi; E Nagata; H R Luo; A M Snowman; S H Snyder
Journal:  J Biol Chem       Date:  2001-08-13       Impact factor: 5.157

Review 2.  Nuclear export of mRNA.

Authors:  D Zenklusen; F Stutz
Journal:  FEBS Lett       Date:  2001-06-08       Impact factor: 4.124

Review 3.  Dbp5, Gle1-IP6 and Nup159: a working model for mRNP export.

Authors:  Andrew W Folkmann; Kristen N Noble; Charles N Cole; Susan R Wente
Journal:  Nucleus       Date:  2011-11-01       Impact factor: 4.197

4.  Inositol polyphosphate multikinase (ArgRIII) determines nuclear mRNA export in Saccharomyces cerevisiae.

Authors:  A Saiardi; J J Caffrey; S H Snyder; S B Shears
Journal:  FEBS Lett       Date:  2000-02-18       Impact factor: 4.124

5.  The GLFG regions of Nup116p and Nup100p serve as binding sites for both Kap95p and Mex67p at the nuclear pore complex.

Authors:  L A Strawn; T Shen; S R Wente
Journal:  J Biol Chem       Date:  2000-12-04       Impact factor: 5.157

6.  PiUS (Pi uptake stimulator) is an inositol hexakisphosphate kinase.

Authors:  M J Schell; A J Letcher; C A Brearley; J Biber; H Murer; R F Irvine
Journal:  FEBS Lett       Date:  1999-11-19       Impact factor: 4.124

7.  Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration.

Authors:  Agnes L Nishimura; Vera Zupunski; Claire Troakes; Claudia Kathe; Pietro Fratta; Michael Howell; Jean-Marc Gallo; Tibor Hortobágyi; Christopher E Shaw; Boris Rogelj
Journal:  Brain       Date:  2010-05-14       Impact factor: 13.501

Review 8.  Inositol pyrophosphates: metabolism and signaling.

Authors:  M Bennett; S M N Onnebo; C Azevedo; A Saiardi
Journal:  Cell Mol Life Sci       Date:  2006-03       Impact factor: 9.261

9.  Structural determinants of the cellular localization and shuttling of TDP-43.

Authors:  Youhna M Ayala; Paola Zago; Andrea D'Ambrogio; Ya-Fei Xu; Leonard Petrucelli; Emanuele Buratti; Francisco E Baralle
Journal:  J Cell Sci       Date:  2008-10-28       Impact factor: 5.285

View more
  4 in total

Review 1.  The inositol pyrophosphate pathway in health and diseases.

Authors:  Anutosh Chakraborty
Journal:  Biol Rev Camb Philos Soc       Date:  2017-12-27

2.  Exosome-Encapsulated microRNA-140-5p Alleviates Neuronal Injury Following Subarachnoid Hemorrhage by Regulating IGFBP5-Mediated PI3K/AKT Signaling Pathway.

Authors:  Pinyan Wang; Yanan Xue; Yuchun Zuo; Yinan Xue; John H Zhang; Jiajia Duan; Fei Liu; Aihua Liu
Journal:  Mol Neurobiol       Date:  2022-09-21       Impact factor: 5.682

Review 3.  The Key Role of IP6K: A Novel Target for Anticancer Treatments?

Authors:  Mirko Minini; Alice Senni; Vittorio Unfer; Mariano Bizzarri
Journal:  Molecules       Date:  2020-09-25       Impact factor: 4.411

4.  Axial Impairment Following Deep Brain Stimulation in Parkinson's Disease: A Surgicogenomic Approach.

Authors:  Naomi P Visanji; Mahdi Ghani; Eric Yu; Erfan Ghani Kakhki; Christine Sato; Danielle Moreno; Taline Naranian; Yu-Yan Poon; Maryam Abdollahi; Maryam Naghibzadeh; Rajasumi Rajalingam; Andres M Lozano; Suneil K Kalia; Mojgan Hodaie; Melanie Cohn; Marta Statucka; Alexandre Boutet; Gavin J B Elias; Jürgen Germann; Renato Munhoz; Anthony E Lang; Ziv Gan-Or; Ekaterina Rogaeva; Alfonso Fasano
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.568

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.